Related Experiment Video
Updated: Jul 31, 2025

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
Differentiation between Descending Thoracic Aortic Diseases using Machine Learning and Plasma Proteomic Signatures
Amanda Momenzadeh1,2,3, Simion Kreimer2,3, Dongchuan Guo4
1Department of Computational Biomedicine, Cedars Sinai Medical Center, Los Angeles, California, USA.
Machine learning effectively distinguished plasma proteomes in descending thoracic aortic aneurysm and type B dissection patients, identifying key proteins for risk stratification.
Area of Science:
- Cardiovascular Medicine
- Proteomics
- Machine Learning
Background:
- Descending thoracic aortic aneurysms and dissections are severe conditions lacking effective screening tools.
- Few clinical indices exist to predict the risk of aortic dissection.
Approach:
- A plasma proteomic dataset was generated from patients with type B dissection and descending thoracic aortic aneurysm.
- Supervised machine learning algorithms were compared with standard statistical methods.
- Proteins were clustered, and machine learning models were trained and optimized using cross-validation.
Key Points:
- Standard statistics identified only one significantly different protein (hemopexin) between the two conditions.
- Machine learning achieved a precision-recall area under the curve of 0.7 for classification.
- Top predictive proteins included immunoglobulin heavy variable genes, lecithin-cholesterol acyltransferase, coagulation factor 12, and hemopexin.
Conclusions:
- Machine learning can differentiate highly similar disease states based on plasma proteomic data.
- This approach aids in prioritizing important proteins for predictive modeling.
- Machine learning offers a novel strategy for identifying biomarkers in complex cardiovascular diseases.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation